SCHEMBL10085752

SCHEMBL10085752

c1ccc(N(c2ccc(-c3c4ccccc4c(-c4ccc(N(c5ccccc5)c5ccc6ccccc6c5)cc4)c4ccccc34)cc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.41
ESR2 Q92731 5/20 0.41
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ACHE P22303 1/20 0.36
GPR84 Q9NQS5 2/20 0.36
ACMSD Q8TDX5 1/20 0.36
ALOX5 P09917 3/20 0.35
PTGES O14684 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
GSTP1 P09211 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10063955 0.98 ESR1 (0.44) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL10063979 0.98 ESR1 (0.44) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL10063935 0.98 ESR1 (0.44) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL10063879 0.97 ESR1 (0.42) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL15887975 0.97 ESR1 (0.45) ESR1ESR2ALDH1A1KDM4ECYP1A2
SCHEMBL10064010 0.95 ESR1 (0.42) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL13777115 0.93 ESR1 (0.39) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL13777122 0.93 ESR1 (0.39) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL13615682 0.93 ALDH1A1 (0.36) ESR1ESR2ALDH1A1KDM4EL3MBTL1
SCHEMBL22671297 0.93 ESR1 (0.39) ESR1ESR2ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8147989-B2 OLED device with stabilized green light-emitting layer GLOBAL OLED TECHNOLOGY LLC (US) 2012-04-03 US disclosed
US-8147989-B2 OLED device with stabilized green light-emitting layer GLOBAL OLED TECHNOLOGY LLC (US) 2012-04-03 US disclosed
US-7888863-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2011-02-15 US disclosed
US-7888863-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2011-02-15 US disclosed
WO-2010098879-A1 OLED DEVICE WITH STABILZED GREEN LIGHT-EMITTING LAYER GLOBAL OLED TECHNOLOGY LLC. (US) 2010-09-02 WO disclosed
US-20100219748-A1 OLED DEVICE WITH STABILIZED GREEN LIGHT-EMITTING LAYER GLOBAL OLED TECHNOLOGY LLC 2010-09-02 US disclosed
US-20100219748-A1 OLED DEVICE WITH STABILIZED GREEN LIGHT-EMITTING LAYER GLOBAL OLED TECHNOLOGY LLC 2010-09-02 US disclosed
WO-2010064871-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2010-06-10 WO disclosed
US-20090295281-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-12-03 US disclosed
US-20090295281-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-12-03 US disclosed
US-20090261714-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-22 US disclosed
US-20090261714-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-22 US disclosed
US-20090260686-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-22 US disclosed
US-20090260686-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-22 US disclosed
EP-2098532-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-09 EP disclosed
EP-2090637-A1 Organic electroluminescent compounds and light emitting diode using the same Gracel Display Inc. (KR) 2009-08-19 EP disclosed
EP-2085450-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-08-05 EP disclosed
US-20090189519-A1 Organic electroluminescent compounds and light emitting diode using the same GRACEL DISPLAY INC. (KR) 2009-07-30 US disclosed
US-20090189519-A1 Organic electroluminescent compounds and light emitting diode using the same GRACEL DISPLAY INC. (KR) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090260686-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, FZD7 ESR1 798/4885ESR2 434/4885ALDH1A1 706/4885
US-20090189519-A1 Organic electroluminescent compounds and light emitting diode using the same OCIAD1, AOX1, OCIAD2 ESR1 165/4885ESR2 193/4885ALDH1A1 39/4885
US-20090261714-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same AOX1, ODC1, LEF1 ESR1 598/4885ESR2 873/4885ALDH1A1 19/4885
US-20090295281-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same AOX1, LEF1, ODC1 ESR1 515/4885ESR2 695/4885ALDH1A1 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.